New medications for asthma.
The therapy for chronic stable asthma and acute asthma exacerbations continues to evolve as the pathogenesis of asthma becomes better understood. Although the role of many standard therapies for asthma is well established, some carry significant side effects. The newer anti-inflammatory medications have demonstrated both therapeutic benefit as well as reassuring safety profiles. The challenge of the future is to incorporate the newer medications described, as well as those still being examined, into a treatment regimen that can deliver maximal therapeutic benefit with the lowest possible incidence of side effects.
Cydulka
R K
RK
Department of Surgery, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Jarvis
H E
HE
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000777:Anesthetics; D018927:Anti-Asthmatic Agents; D018680:Cholinergic Antagonists; D020024:Leukotriene Antagonists; D000628:Aminophylline; D008278:Magnesium Sulfate